A Phase 1b trial to evaluate procizumab (PCZ; AK1967) in critical cardiovascular care.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518450-16-00

Acronym

CT-P1-002

Enrollment

101

Registered

2025-04-08

Start date

2025-06-13

Completion date

Unknown

Last updated

2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic shock due to either acute coronary syndrome (ACS) or sepsis.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Czechia, France, Netherlands, Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026